De Novo device
Sunrise
Sunrise SA · Device For Sleep Apnea Testing Based On Mandibular Movement (QRS, Class II) · First FDA decision Jan 7, 2022, newest Aug 29, 2025Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
De Novo pathway
Device trials
14
Naming "Sunrise"
MAUDE reports
3
Brand "Sunrise", since 2015
PubMed studies
1,503
Mentioning "Sunrise"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sunrise
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- Sunrise510(k)
K250874 · Decided Aug 29, 2025 · 158 days after receipt
Device type: Device For Sleep Apnea Testing Based On Mandibular Movement (QRS) · Otolaryngology (ENT)
- Sunrise510(k)
K222262 · Decided Dec 22, 2022 · 147 days after receipt
Device type: Device For Sleep Apnea Testing Based On Mandibular Movement (QRS) · Otolaryngology (ENT)
- Sunrise Sleep Disorder Diagnostic AidNew device typeDe Novo
DEN210015 · Decided Jan 7, 2022 · 280 days after receipt
Device type: Device For Sleep Apnea Testing Based On Mandibular Movement (QRS) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sleep Testing for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00405NUpdated Sep 23, 2026
- Sleep Testing for Obstructive Sleep Apnea (OSA)National determinationOn the books240.4.1Updated Nov 17, 2023
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093R2Updated Sep 17, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093RUpdated Sep 17, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA)National analysisReview closedCAG-00093NUpdated Sep 15, 2026
- Continuous Positive Airway Pressure (CPAP) Therapy For Obstructive Sleep Apnea (OSA)National determinationOn the books240.4Updated Aug 17, 2023
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep ApneaLocal determinationIn effectL38387Wellpoint FederalUpdated Jul 14, 2026
- Hypoglossal Nerve Stimulation for Obstructive Sleep ApneaLocal determinationIn effectL38276Palmetto GBAUpdated May 8, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Sunrise", any status and sponsor, newest update first.
- Study of the BioRISE Biolimus Drug-Coated Balloon Versus the SELUTION SLR Sirolimus-Coated Balloon in De Novo Coronary Lesions, With a Single-Arm In-Stent Restenosis Cohort (SUNRISE)Pivotal-lookingNot yet recruiting
Biosensors Europe SANot on our public-company list
NCT07938060 · 443 participants (planned) · Start Mar 1, 2027 · Primary completion Jan 31, 2029
Device: Biolimus A9 Drug Coated Balloon; SELUTION SLR · For: Angina (Stable); Unstable Angina (UA); NSTEMI
Sites: Bournemouth, United Kingdom; Bristol, United Kingdom
- Orthognathic Surgery and Obstructive Sleep Apnea Assessed by Mandibular Jaw Movement Monitoring (SUNRISE-ORTHO)Not yet recruiting
CHR Sambre et Meuse Site MeuseAcademic, hospital or other
NCT07910461 · 25 participants (planned) · Start Nov 4, 2026 · Primary completion Jun 15, 2027
Device: Sunrise mandibular jaw movement monitoring · For: Obstructive Sleep Apnea; Sleep Apnea, Obstructive; Dentofacial Deformities
Sites: Namur, Belgium
- Treatment Failure of Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea Syndrome (OSA): A Trial Comparing Polysomnography and the Sunrise Device to Drive Treatment-Adjustment Decisions.Pivotal-lookingRecruiting
University Hospital, GrenobleAcademic, hospital or other
NCT07530302 · 105 participants (planned) · Start Jun 10, 2026 · Primary completion Sep 2029
Device: Sunrise · For: Sleep Apnea Syndrome, Obstructive
Sites: Grenoble, France
11 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sunrise", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 3 injury, 0 death
Whole product code QRS
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- SUNRISEInjury
MW5057655 · Received Oct 31, 2015 · Event dated Oct 14, 2015
Device type: EHR/MDDS (NSX)
Device problem as coded: Fail-Safe Problem
Patient problem as coded: Overdose
- SUNRISEInjury
MW5043000 · Received Jun 4, 2015 · Event dated May 29, 2015
Device type: CPOE/EHR (LNX)
Device problem as coded: Use of Device Problem
Patient problem as coded: No Code Available
- SUNRISEInjury
MW5044520 · Received Mar 1, 2015 · Event dated Jan 8, 2015 · 1 other device named on this report
Device type: Medical Device Data System (OUG)
Device problem as coded: Patient Data Problem
Patient problem as coded: Misdiagnosis
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sunrise"[tiab]. The summary above synthesizes these.
- Sunrise Over Baltimore.
Nichols DG · Pediatrics · 2023Research Support, Non-U.S. Gov't
- Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, et al. · Lancet · 2023Randomized Controlled Trial, Clinical Trial, Phase III
- Sunrise--sunset.
Leever DL · Am J Orthod Dentofacial Orthop · 1997Editorial
- Contemplation.
Poldiak NP · HCA Healthc J Med · 2023
- Charon's refractory factory.
Raut U, Teolis BD, Kammer JA, et al. · Sci Adv · 2022
- Artist's Statement: Sunrise.
Cusick KK · Acad Med · 2024
- Sunrise, High Noon, Sunset.
Wells M, Fosse C, Casamassimo P · Pediatr Dent · 2025
- Sunrise, sunset.
Drone JW · J Indiana Dent Assoc · 2010Editorial
- Yilin Hu.
Angew Chem Int Ed Engl · 2020
- Revisiting the SUNSHINE and SUNRISE trials.
Kimball AB, Ravichandran S · Lancet · 2024Letter, Comment
- February Sunrise.
JAMA Intern Med · 2018
- Sunset and sunrise.
Alpert JS · Am J Med · 2005Editorial, Historical Article
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.